Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

SNURF Inhibitors

The "SNRPN upstream open reading frame" (SNRPN UORF) is a component of the SNRPN (Small Nuclear Ribonucleoprotein Polypeptide N) gene locus, which plays a critical role in the genetic and epigenetic regulation of a cluster of imprinted genes in the Prader-Willi/Angelman syndrome (PWS/AS) region on chromosome 15q11-q13. Not a protein itself, the UORF is a regulatory element located in the 5' untranslated region (5' UTR) upstream of the SNRPN coding sequence.The SNRPN gene is essential for the biogenesis of small nuclear ribonucleoproteins (snRNPs), which are critical components of the spliceosome, the complex responsible for pre-mRNA splicing. The SNRPN UORF plays a regulatory role in the control of SNRPN translation. UORFs are known to be involved in the translational regulation of mRNAs, and their presence can attenuate the translation of the main downstream open reading frame (ORF) by various mechanisms, including ribosome stalling or premature translation termination.

In the context of SNRPN, the UORF is part of a highly complex imprinted domain subject to parental imprinting, a form of epigenetic regulation that results in the gene being expressed exclusively from one parental allele. In the case of SNRPN, it is typically the paternally inherited allele that is active, while the maternal allele is silenced. This imprinting is crucial for normal development, and disruptions in the imprinting process at the SNRPN locus can lead to neurodevelopmental disorders such as Prader-Willi syndrome, which is characterized by intellectual disability, behavioral problems, and obesity, or Angelman syndrome, which includes severe intellectual and developmental disability, seizures, and problems with movement and balance.The SNRPN UORF, by modulating the translation of SNRPN, may indirectly influence the expression of other genes in the PWS/AS region, contributing to the fine-tuned regulatory network that is essential for neurodevelopment and metabolic functions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that can demethylate DNA and potentially alter the expression of genes regulated by methylation, including SNRPN.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

A non-nucleoside DNA methyltransferase inhibitor, potentially affecting the methylation status of the SNRPN gene locus.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

Another DNA methyltransferase inhibitor, used to reactivate genes silenced by hypermethylation, potentially including SNRPN.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

A histone deacetylase (HDAC) inhibitor that can alter chromatin structure and increase gene expression, possibly affecting SNRPN.

Panobinostat

404950-80-7sc-208148
10 mg
$196.00
9
(1)

A potent HDAC inhibitor, affecting gene expression and could influence the SNRPN gene expression.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$214.00
$622.00
1
(1)

An HDAC inhibitor that can change the expression patterns of genes through epigenetic modulation, potentially impacting SNRPN.

Valproic Acid

99-66-1sc-213144
10 g
$85.00
9
(1)

An HDAC inhibitor with broad-spectrum activity, which may affect the expression of genes like SNRPN.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

A specific inhibitor of histone deacetylase, altering the acetylation status of histones and affecting gene expression.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$88.00
$208.00
24
(2)

A selective HDAC inhibitor that could modulate the expression of genes involved in PWS, including SNRPN.

SGI-1027

1020149-73-8sc-473875
10 mg
$209.00
(0)

An inhibitor of DNA methyltransferase, potentially demethylating the SNRPN locus and affecting its expression.